719. Susceptibility Testing of Oteseconazole (VT-1161) Against Clinical Isolates from Phase 3 Clinical Studies in Subjects with Recurrent Vulvovaginal Candidiasis

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 8; no. Supplement_1; p. S459
Main Authors Ghannoum, Mahmoud, Degenhardt, Thorsten, Person, Karen, Brand, Stephen
Format Journal Article
LanguageEnglish
Published 04.12.2021
Online AccessGet full text
ISSN2328-8957
2328-8957
DOI10.1093/ofid/ofab466.916

Cover

Author Ghannoum, Mahmoud
Person, Karen
Brand, Stephen
Degenhardt, Thorsten
Author_xml – sequence: 1
  givenname: Mahmoud
  surname: Ghannoum
  fullname: Ghannoum, Mahmoud
  organization: Case Western Reserve, Cleveland, Ohio
– sequence: 2
  givenname: Thorsten
  surname: Degenhardt
  fullname: Degenhardt, Thorsten
  organization: Mycovia Pharmaceuticals, Inc., Durham, North Carolina
– sequence: 3
  givenname: Karen
  surname: Person
  fullname: Person, Karen
  organization: Mycovia Pharmaceuticals, Inc., Durham, North Carolina
– sequence: 4
  givenname: Stephen
  surname: Brand
  fullname: Brand, Stephen
  organization: Mycovia Pharmaceuticals, Inc., Durham, North Carolina
BookMark eNp1kE9LAzEQxYMoqNW7xxz1sHXSbLOboxT_FAoVrV6X2STbjqyJbFKlfhw_qVsUFMHLzMB7bx78DtmuD94xdiJgKEDL89CQ7QfWuVJDLdQOOxjJUZmVelzs_rr32XGMTwAgBIyh0AfsoxB6yO_X0biXRDW1lDZ84WIiv-Sh4fPkojPB43toHT99XGRCKHHGL5ZIPiY-acmTwZZPY2ixN_OmC8_8doXRcfkj36e1pV4l35fVT86kyN8orfidM-uucz7xx3X7Gl5xSb73T9BbsoSR4hHba7CN7vh7D9jD1eVicpPN5tfTycUsM0KCygqJpShgpFBoWUKDYiya2loFhTSmtqAVWFsDWmVA1E7mdaFlrvJSjZU2uRww-PpruhBj55rqpaNn7DaVgGqLudpirr4xVz3mPqL-RAwlTBR86pDa_4OfNcCIGA
CitedBy_id crossref_primary_10_1128_cmr_00074_23
crossref_primary_10_1007_s40265_022_01734_y
crossref_primary_10_1080_14787210_2023_2233696
crossref_primary_10_17925_ID_2022_1_1_16
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1093/ofid/ofab466.916
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2328-8957
EndPage S459
ExternalDocumentID 10_1093_ofid_ofab466_916
GroupedDBID 0R~
53G
5VS
7X7
8C1
8FI
8FJ
AAFWJ
AAMVS
AAPXW
AAVAP
AAYXX
ABDBF
ABEJV
ABGNP
ABPTD
ABUWG
ABXVV
ACGFS
ACUHS
ADBBV
ADHZD
ADPDF
AENZO
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMNDL
AOIJS
BAWUL
BAYMD
BCNDV
BENPR
CCPQU
CIDKT
CITATION
DIK
EBS
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
IHR
ITC
KQ8
KSI
M48
M~E
O9-
OAWHX
OJQWA
OK1
OVD
OVEED
PEELM
PHGZM
PHGZT
PIMPY
RPM
TEORI
TJX
TOX
UKHRP
ID FETCH-LOGICAL-c1306-73a817026a19380fa151fbdd6073ccbd0960ddb0ad6c01be34b79346486569c43
IEDL.DBID M48
ISSN 2328-8957
IngestDate Tue Jul 01 00:49:12 EDT 2025
Thu Apr 24 23:10:16 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement_1
Language English
License https://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1306-73a817026a19380fa151fbdd6073ccbd0960ddb0ad6c01be34b79346486569c43
OpenAccessLink https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S459/41527539/ofab466.916.pdf
ParticipantIDs crossref_primary_10_1093_ofid_ofab466_916
crossref_citationtrail_10_1093_ofid_ofab466_916
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-04
PublicationDateYYYYMMDD 2021-12-04
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-04
  day: 04
PublicationDecade 2020
PublicationTitle Open forum infectious diseases
PublicationYear 2021
SSID ssj0001105079
Score 2.1910298
SourceID crossref
SourceType Enrichment Source
Index Database
StartPage S459
Title 719. Susceptibility Testing of Oteseconazole (VT-1161) Against Clinical Isolates from Phase 3 Clinical Studies in Subjects with Recurrent Vulvovaginal Candidiasis
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ1LS8QwEICDDxAv4hPfzMGDHrK2m2zaHkREFBVWRXfFW8mjXRdKV60r6s_xlzrTjY-DHrz00rSFTNL5ZjIPxrYCk1MGseXSZgmXmQh4rJXjBvFB2GYeuohyh9vn6qQrz25bt9_p0X4Cq19NO-on1X0sGi8Pr_u44fd8MaRdlILDizZSqQbizjibRL0UUSOHtof92uOCKBHUxfeQImIeJ63In1v-9pIfeuqHwjmeZTOeFOFgJNo5NpaV82yq7c_CF9h7FCYNuB5WdWBKHeP6Ch0qmlH2YJDDBUIkWbv6bVBksH3T4SFy1w4c9HQfmRB8RdACTnH5EXECpZrA5R3qNRDft32kIfRL_Jght00F5L2FK3LVU3EnuBkWz4NnXXfYgkNKlMFVV_WrRdY9PuocnnDfcYFb1GWKR0JTwb6m0sh1cZBr5IHcOKfwR2CtcWTvOGcC7ZQNQpMJaXB_SyVjxMLESrHEJspBmS0zUAbByBoR58aiDRcncYiwY1u5QAbKlFxhu5_zm1pfjpy6YhTp6FhcpCSR1EskRYmssJ2vJ-5HpTj-HLv6j7FrbLpJgSoUoyLX2cTT4zDbQNJ4Mpu1hb5ZL6MPpBHUPw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=719.+Susceptibility+Testing+of+Oteseconazole+%28VT-1161%29+Against+Clinical+Isolates+from+Phase+3+Clinical+Studies+in+Subjects+with+Recurrent+Vulvovaginal+Candidiasis&rft.jtitle=Open+forum+infectious+diseases&rft.au=Ghannoum%2C+Mahmoud&rft.au=Degenhardt%2C+Thorsten&rft.au=Person%2C+Karen&rft.au=Brand%2C+Stephen&rft.date=2021-12-04&rft.issn=2328-8957&rft.eissn=2328-8957&rft.volume=8&rft.issue=Supplement_1&rft.spage=S459&rft.epage=S459&rft_id=info:doi/10.1093%2Fofid%2Fofab466.916&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ofid_ofab466_916
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2328-8957&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2328-8957&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2328-8957&client=summon